Evaluation of TNM Classification of Carcinoma of the Breast by Sicher, K. & Waterhouse, J. A. H.
Br. J.Cancer (1973) 28, 580
EVALUATION OF TNM CLASSIFICATION OF CARCINOMA
OF THE BREAST
K. SICHER esi J. A. H. WATERHOUSE
From the Corenfry and Warwickshire Hospital anid
Birmingham Regional Caneer Registry
Received 10 Julv 1973. Accepted 6 September 1973
Summary.-A survey of the records of almost 2000 cases of carcinoma of the breast
in the years 1960-67, since acceptance of the principles of the TNM system of clas-
sification, found only 9.20o lacking description. Although the TNM staging was
not always allocated by the surgeon making the initial examination, the survey
demonstrated that acceptance of the system has resulted in the inclusion of a much
more detailed clinical description by the surgeon in the patient's record, from
which it was generally possible to assess the TNM staging in the Radiotherapy
Department. The more detailed survival rates available in the case of the TNM
system, in comparison with the Manchester staging system, is cited as a further
recommendation for its wider use. Although detailed localization of the tumour
to subsites within the breast appears to have little influence on prognosis, the addi-
tion of a supplementary histological classification of node involvement is a valuable
adjunct to the assessment of likely survival.
THE DIPORTANCE of clinical classifica-
tion of malignant tumours is implicit in
anv worthwhile assessment of the relative
efficacy of treatment regimens. In the
field of mammary cancer in part,icular,
much of the management of which is
still a subject of controversy, evaluation
of the relative merits of different methods
of treatment depends essentiallv upon an
accurate description of the initial findings
in conveniently concise and readily accept-
ed terms. Clinical trials are current in
this and in other countries to test and
compare alternative treatments, but the
validity of their results and the relevance
of comparisons between them hinge on
the successful application of methods of
description of the growth based on the
same, generally accepted, principles for
all centres. The TNMf system as recom-
mended by the International Union
against Cancer (U3ICC) in 1959 sets out
to fulfil this function and experience of
its use in breast cancer is now becoming
more extensive. It was recommended at
the IXth International Cancer Congress
in 1966 that the system shouldbe accepted
internationally, for an initial period of at
least 5 years.
The principles of TNM staging of
breast tumours, as described in the British
Journal of Surgery (1960) or in the
UICC's booklet (1968)* were formallv
accepted for implementation by both
surgeons and radiotherapists in the Birm-
ingham Region soon afterwards. This
paper sets out to make a preliminary
assessment of the extent to which the
recommendations have been followed in
two of the Hospital Groups of the region
(Groups 14 and 20), and to compare it
with the 'Manchester system of staging
which had been in general use for many
years. At the same time comparisons
are also made of the TIYM classification
with histological evidence of axillarv
node involvement, as well as with the
situation of the tumour within the breast.
* A new edition of this Booklet was produced in 1972, proposing some modifications for use in the
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TABLE I.-Number of Cases Staged by Year ofRegistration
Staging 1960 1961 1962 1963 1964 1965 1966 1967
TN-\M and 'Manchester 190 173 187 210 176 179 206 200
T\-NM onlv 3 14 5 6 25 17 21 9
Manchester only 10 10 13 3 30 38 33 34
Neither 14 31 34 25 15 21 17 24
Total 217 228 239 244 246 255 277 267
The period oftime covered is 1960-67.
Table I shows that the proportion of
cases staged has not altered much in
this time. A specially devised form
giving full details of the TNM criteria is
included in the records of each case.
It is made clear that the TN.M staging
should be made at the first examination
but unhappily this condition was not
invariably observed. The description of
the growth, primary and secondaries,
given by the surgeons was, however,
sufficiently detailed in most cases for
TNM assessment in the radiotherapy
department. While on occasions the
TNM staging is omitted, the information
now given by the surgeons is much more
detailed than it was before the scheme
began. The simple direction " carcinoma
breast-for mastectomy " has fortunately
disappeared, and contrasts sharply with
the present full and adequate description
ofthe growth now given by the surgeons-
an example which is followed also by their
junior staff from registrars down. In
nearly 2000 cases, for instance, only
9.20/0 were not staged at all and both
TN1M and Manchester systems were re-
corded for 77-1%.
Table II and Fig. 1 show the overall
distribution by Manchester staging. Stage
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TABLE II.-Manchester Staging
DNumber 0
I 740 43-7
I 491 29-0
I 252 14 9
1 209 12-4
tal staged 1692 100-0 85-
t staged 281 14-2
Total 1973 100 C
I at 43-7% is the largest group, while
14-2% had inadequate information for
assessment of stage. The distribution by
TNM system is shown in Table III, and
in Fig. 2. As can be seen, only 2.4% had
distant metastases (M1).
A more detailed breakdown of the
TNKM cases is made in Table IV, which
shows the largest single group of cases
to have been classified as T2No. A com-
parison of the TNM and Manchester
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40
30
20
10
0
FIG. 1.-Distribution bv Manchester staging.
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TABLE V.-C'omparison of TNM Classifi-
cation and Manchester Staging
TNlm
classification
T1N03
T25 XNoAO TX,NM*
T3- 031
T4MN83
T,N1lM0 T2NI1M
T3N1m0
T4N1MO
TIN-231
T1SN2M
T2-N-MO
T3N2
T4N2M0
T1N-3M*
T2,N3M0
T3N-3Mo
T4NX3mO
Manchester stage
I
111
456
104
4
II Im
1
9 4
6 75
25
1 303
- 112
1 1
12
77
14
IV
6
4
1
11
9
2 2 1 3 19 6
1 8 28
2 6
3 16
2 33
677 462 226 123
N.K.
9
32
8
6
19
17
1
5
1
1
94
Total
114
501
199
21
26
337
217
27
5
29
42
8
20
36
No TN3 62 28 23 58 181 352
Total 739 490 249 181 275 1934
Thirty-nine cases with distant metastases are
excluded 8al were Manchester stage IV.
systems is presented in Table V, which
demonstrates well the wider variety of
TN7M classification compared with the
Manchester staging, and underlines the
shortcomings of the latter system when
used as a basis for comparison oftreatment
results between different centres.
TNMJI and histological stages negative"
and " positive "
It is generally accepted that clinical
assessment of significant glandular in-
volvement is not very accurate, even
when made by an experienced clinician,
and that it mav varv appreciablv from
one clinician to another. The extent
of this inaccuracy is revealed for our
cases in Table VI, which compares clinical
and histological findings. Here it is
TABLE VI.-Involvemend of Nodes: Com-
parison of Clinical and Histological
Findings
NO
N1
N\K2
X3
XN.K.
Nodes negative
No. 0
270 (59-7)
132 (31-3)
2 (10-5)
2 (28-6)
81 (56-6)
Nodes positive
No. 00
182 (40-3)
290 (68-7)
17 (89-5)
5 (71 4)
62 (43-4)
Total
No.
452
422
19
1
143
Total 487 (46 7) 556 (53-3) 1043
apparent that in 40% of cases in which
no glands were palpable microscopical
examination confirmed the presence of
malignancy. -Almost more surprising,
however, is the percentage of cases in
which enlarged lymph nodes were found
clinically which histologically turned out
to be negative. The discrepancy ap-
peared in nearlv a third ofthe cases.
Surrival
Five-vear survival rates, crude and
age-adjusted, are shown in Table VII
according to the separate divisions of the
TNM system, and in Table VIII crude
rates for each of the subgroups of TNM0,
which are also presented graphicallv in
Fig. 3. Of the 1582 cases staged on the
TNM system and without distant meta-
stases, 50-1./ survived a years. A little
surprisingly perhaps, it will be noted
from Table VIII that the survival of
TABLE VII.-5-Year Surtivaml Rates by T.N'Mo
T (tujmour)
A
0 0
o0 0
78-6 (140) 81-9
60-3 (851) 66-7
33-1 (465) 37-6
11-9 (126) 13-8
NO
X1
N2
N-3
N (nodes)
0 0
0 0
61-1 (835) 68-2
43-7 (607) 48-9
14-5 (76) 15-9
9-4 (64) 10-6
M (metastases)
o o 5o (o
me 50 1 (1582) ii-8
Age-adjusted survival rates given in italics. Thirty-nine cases with distant metastases (M,) are
excluded; 352 cases were not classified for TN-M: their crude 5-year s-urvival rate was 34. 40O
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I
III
IV
I-IV
N.K.
Tot
TABLE IX.-5-Year Surrival Rates by Manchester Staging
Surival rate (Oo)
K
Nuimber 00 Crude Adjusted
740 (43-7) 67-9 73-8
491 (29-0) 49.9 54-7
252 (14-9) 24-2 28-4
209 (12-4) 6-2 73
1692 (100-0) (85-8) 48-1
281 (14-2) 37-0
al 1973 (100-0) 46-5
80
60
40
20
0
66.9..
I II
FIG. 4.-5-year survival rate
comparisons such as these that the TNM1
system, because it gives a more detailed
description of the advancement of the
disease, can help in providing a more
accurate prognosis bv each of its sub-
divisions.
The influence of site in relation to TNMJI
grading
We have attempted to assess the
effects of the localization of the tumour
within the breast on the subsequent
survival, and at the same time in relation
4V L ILL
CASES
'4.,"
n 21.
-I-I
6-2z
l~
III IV
(O/) by Manchester staging.
to the TNM grading. We have used
3 subsites medial, lateral and subareolar
-to describe the situation of the tumour,
together with a composite group
' other "
for growths which did not fit into anv
of the 3 principal categories. Table X
shows the 5-vear survival rates for these
subsites in relation to the extent of the
tumour (T). There is virtuallv no dif-
ference in survival rates between medial
and lateral subsites, at each tumour
grading, nor between them and other
sites: the subareolar growths show the
53-9
44-3
52-6
mmb mol immmi 6= 6MEMII
n
FMM=q
a
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TABLE X.-5-Year Survival Rates by Site and Extent ofPrimary Tumour
Medial Lateral Sub-A Other All known s
0O No. 0 No. 0 No. 0 No. 0 No.
74-1 (27) 75-4 (61) 92-9 (14) 77-8 (18) 77-5 (120)
64-9 (171) 60-6 (388) 58-7 (75) 61-8 (68) 61-5 (702)
35-4 (79) 35-6 (191) 24-6 (57) 34-0 (53) 33-7 (380)
0-0 (10) 22-6 (31) 12-5 (24) 7-5 (40) 12-4 (105)
55-4 62-5 53-1 58-4 43-5 48-0 43-0 49-2 51-0 (1307)
Sites
84-
68-
37-
14-
-56-
-3
1
3
Age adjusted surv-iv-al rates are given in italics.
TABLE XI.-5-Year Crude Survival Rates by Node Involvement and Site ofPrimary
Medial Lateral Sub-A Other
O0 No. 0 No. 0 No. 0 No.
NO 59-7 (191) 65-1 (335) 61-0 (77) 56-2 (89)
N1 46-4 (84) 45-7 (291) 35-2 (71) 44-2 (52)
TABLE XI.-5-Year Crude Survival Rates by Clinical and Histological Involvement
ofNodes and Site ofPrimary
Medial
00 -No.
NO- 81-5 (27)
- 40-7 (27)
Lateral
0o No.
87-3 (71)
44-6 (74)
Sub-A
00 No.
87-5 (16)
40-0 (20)
Other
0 No.
60-0 (25)
38-9 (18)
N1- 58-8 (17) 76-2 (42) 54-5 (11) 62-5 (8)
- 50-0 (24) 42-0 (119) 36-4 (33) 59-1 (22)
best rates for T1 (based on 14 cases) but
poorer rates for T2 and T3. In Table XI
the effects of node involvement and site
are shown, and it can be seen that lateral
growths have the best rates; again the
subareolar, when nodes are clinicallv
involved, shows the poorest survival.
The numbers of cases for N2 and N3 were
too small to warrant separate subdivision
and are therefore combined. Table XII
breaks down the main categories of the
previous table by histological evidence
of node involvement. Clearly, the effect
is much more pronounced where the
nodes were clinically considered not to
be involved: those cases with histological
involvement have about half the survival
rate of those without such evidence, and
this is broadlv true of each subsite.
The effect of histological evidence on the
survival rate is much less marked in the
case of the N1 group, where of course the
numbers of cases judged to be clear
histologically is relatively small. None-
theless, there is a real difference in the
survival rates overall, greatest in laterally
situated tumours and least in others ".
DISCUSSION
We would claim that our experience
proves that the use of the TNM classifica-
tion is a practicable proposition, and that
its value in respect of survival rates and
prognosis generally is at least as good as
that of the Manchester staging. Our
findings thus correspond to those of the
Royal Marsden Hospital (Harmer, 1963).
Since the TNM classification has been
formally accepted in our region, the
quality of the clinical case records has
improved very considerably, a fact which
by itself is a praiseworthy achievement.
Only a relatively small percentage of
cases received an inadequate description
and could therefore not be staged.
WVe consider that the impact of the
formal acceptance of the principles of
TNM, taken together with the existence
586
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of the investigation reported here. though
they have not fully succeeded in their
object of achieving 10000 T INM staging,
have re-emphasized the value ofa detailed
clinical description in the notes and we
hope may stimulate further efforts because
of its evident advantages in prognostic
value. We consider it most desirable
that a special questionnaire form should
be included in the records and completed
at the patient's first visit to the hospital.
MacKay and Sellers (1966) have proposed
that only 3 degree-s of local extent be
recorded and that T1 and T2 should be
combined. In our experience such a
condensation would detract from the
value of the TYNM system. and we would
rather see further subdivisions providing
for more detailed description of the
primary growth and its extension. In
this connection it is worth notingf the
experience of the Stockholm evaluation
of carcinoma of the cervix uteri (Kott-
meier, 1967) where it has been found
necessary to add further subdivisions to
the conventional 4 stages of classification.
W\e would. however, lik-e to support the
recommendations of MacKay and Sellers
for special studies on the subject of
pectoral muscle fixation. where it seems
desirable that a differentiation of incom-
plete from complete muscle fixation should
be made.
There are two features of the primary
gro-th (T) for which the TXNM system
does not provide. In the first place,
the size and type of the breast itself are
of importance. not only the absolute size
of the primary growth. For example,
it is a matter of clinical experience that
the significance of a tumour 5 cm in
size in a small poorly developed breast is
very different from that of a mass of the
the same size in a large breast: a large
tumour in a small atrophic breast is
more likely to involve deeper structures
than it is to be confined to the mamma
itself, as it may be in a larger breast.
Secondly, the classification takes no con-
sideration of whether only one mass is
present or whether several are palpable
44:
in the breast area. Furthermore, while
T-NI is accepted, and rightly so, as a
clinical staging system, the addition of
the supplementary histological classifica-
tion is a valuable adjunct. This can be
simply indicated by attaching symbols
+ and' to the various categories
of nodes (N), as is recommended by the
UI1CC. The subsite of the primary tu-
mour, on the other hand, represents a
factor which, though it might be thought
to be of importance in the prognosis of
mammary carcinoma, seems to exert
relatively little influence in comparison
with the other criteria we have presented.
APPENDIX
Sutimnary of T-N-M and Manchester
cla.ssifications
T'N\-M
T1 Tumour diameter 2 cm or less: no
fixation and no nipple retraction.
T, Tumour diameter more than 2 cm but
less than 5 cm: or less than 5 cm. but
with tethering or dimpling of over-
lying skin. or retraction of nipple.
T3 Tumour diameter more than 5 cm but
less than 10 cm: or less than 10 cm.
but with infiltration or ulceration of
skin or peau d'orange over tuimour,
or with fixation to pectoral muscle.
T4 Tumour diameter more than 10 cm, or
tumour of any size. but mith infiltra-
tion or ulceration of skin or peau
d'orange weide of tumour. or with
fixation to chest wall.
N0 No palpable axillary ]ymph nodes.
-X Axillarv l-mph nodes. mobile.
N-2AxiHarv- lymph nodes fixed to each
other or to other structures.
-3 With or mithout axillarv lymph nodes.
but supraclavicular or infraclavicular
or parasternal lymph nodes. mobile
or fixed: or oedema of arm.
-0 No evidence of distant metastases.
311 Distant metastases including skin wide
of breast. or involvement of opposite
breast or nodes. or other metastases.a88 K. SICHER AND J. A. H. WATERHOUSSE
MA-CHESTER STAGING
I Confined to breast; involvement of skin
small; no palpable lvmph nodes.
II As for Stage I but with palpable mobile
nodes in axilla.
III (a) Skin ulcerated, or fixed, over large
area, and peau d'orange. (b) Fixa-
tion to underlying muscle; any pal-
pable nodes mobile.
IV Extension ofgrowth beyond breast area.
as shown by (a) fixation of axillary
nodes, (b) fixation of tumour to chest
wall. (c) secondary nodes in supra-
clavicular region. (d) secondarv skin
deposits wide oftumour, (e) secondary
deposits in opposite breast, (f) distant
metastases, e.g. bone, liver. lung. etc.
We should like to record our indebted-
ness to Miss Barbara Cornes for her help
in the preparation and editing of the data
for analysis, for much of the tabular
material, and for the illustrations.
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